ArticleJournal of primary care & community health

Clinical Outcomes of Switching U-100 Intermediate or Basal Insulin to U-200 Insulin Degludec or U-300 Insulin Glargine.

Natalie Rosario et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.